Shares of Hansen Medical (HNSN -12.3%) take another leg down after its Q2 came up far short of estimates late yesterday. Revenues fell 34.0% year over year to $3.5M, $2.8M below consensus, as its cost of revenues jumped to 26% due to lower system sales and R&D expenses nearly doubled.
Check out Seeking Alpha’s new Earnings Center »
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs